Top compounds associated with response to RP11-166N6.3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.0002 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.00015 1
mRNA momelotinib CTRPv2 pan-cancer AAC -6.9e-05 1
mRNA BIBW2992 CTRPv2 pan-cancer AAC 7.2e-05 1
Download CSV